Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
Zhang J, Boesjes CM, Loman L, Kamphuis E, Romeijn MLE, Spekhorst LS, Haeck I, van der Gang LF, Dekkers CC, van der Rijst LP, Oosting AJ, van Lumig P, van Lynden-van Nes AMT, Tupker RA, Nijssen A, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, de Graaf M, de Bruin-Weller MS, Schuttelaar MA. Zhang J, et al. Among authors: schuttelaar ma. J Am Acad Dermatol. 2024 Apr 21:S0190-9622(24)00641-8. doi: 10.1016/j.jaad.2024.04.026. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38653344
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Spekhorst LS, Boesjes CM, Loman L, Zuithoff NPA, Bakker DS, Kamphuis E, Kamsteeg M, Haeck IM, Oosting AJ, van Lumig PPM, van Lynden-van Nes AMT, Tupker RA, Flinterman A, Garritsen FM, Touwslager WRH, de Bruin-Weller MS, Schuttelaar MA, de Graaf M. Spekhorst LS, et al. Among authors: schuttelaar ma. Br J Dermatol. 2023 Aug 24;189(3):327-335. doi: 10.1093/bjd/ljad159. Br J Dermatol. 2023. PMID: 37177895
Analysis of Hexavalent Chromium in Cement Samples From Countries Within and Outside the EU: A Study From the International Contact Dermatitis Research Group.
Lejding T, Persson L, Andersen KE, Bruze M, Derevyanko L, Elsner P, Goh CL, Gonçalo M, Goossens A, Gülgün MA, Isaksson M, Ljubojevic Hadzavdic S, Maibach H, Matsunaga K, Mowitz M, Nixon R, Pailin P, Pratt M, Schuttelaar MA, Sukakul T, Verma K, Zimerson E, Özkaya E, Svedman C. Lejding T, et al. Among authors: schuttelaar ma. Dermatitis. 2023 Jul-Aug;34(4):323-328. doi: 10.1089/derm.2022.0053. Epub 2023 Mar 31. Dermatitis. 2023. PMID: 37001151
Patch test results with the European baseline series, 2019/20-Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC.
Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Brans R, Buhl T, Dickel H, Dugonik A, Filon FL, Garcìa PM, Giménez-Arnau A, Patruno C, Pesonen M, Pónyai G, Rustemeyer T, Schubert S, Schuttelaar MA, Simon D, Stingeni L, Valiukevičienė S, Weisshaar E, Werfel T, Gonçalo M; ESSCA and EBS ESCD working groups, and the GEIDAC. Uter W, et al. Among authors: schuttelaar ma. Contact Dermatitis. 2022 Oct;87(4):343-355. doi: 10.1111/cod.14170. Epub 2022 Jun 24. Contact Dermatitis. 2022. PMID: 35678309 Free article.
European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC.
Uter W, Wilkinson SM, Aerts O, Bauer A, Borrego L, Buhl T, Cooper SM, Dickel H, Gallo R, Giménez-Arnau AM, John SM, Navarini AA, Pesonen M, Pónyai G, Rustemeyer T, Schliemann S, Schubert S, Schuttelaar MA, Valiukevičienė S, Wagner N, Weisshaar E, Gonçalo M; ESSCA and EBS ESCD working groups, and the GEIDAC. Uter W, et al. Among authors: schuttelaar ma. Contact Dermatitis. 2022 May;86(5):379-389. doi: 10.1111/cod.14059. Epub 2022 Feb 17. Contact Dermatitis. 2022. PMID: 35099073
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions.
Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerts O, Uter W, Wilkinson M, Gimenez-Arnau A. Balato A, et al. Among authors: schuttelaar ma. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e353-e354. doi: 10.1111/jdv.16557. Epub 2020 Jun 8. J Eur Acad Dermatol Venereol. 2020. PMID: 32356382 Free article. No abstract available.
A survey of members of the European Surveillance System on Contact Allergy and the EU project "StanDerm" to identify allergens tested in cosmetic series across Europe.
Horton E, Wilkinson M, Aalto-Korte K, Pesonen M, Bauer A, Chowdhury MMU, Cooper S, Cousen P, Crépy MN, Larese Filon F F, Gallo R, Geier J, Giménez-Arnau A, Gonçalo M, Goossens A, Green C, Guarneri F, Ljubojević Hadžavdić S, Johansen JD, Johnston GA, Rustemeyer T, Sánchez-Pérez J, Thyssen JP, Schuttelaar MA, Stone N, Uter W. Horton E, et al. Among authors: schuttelaar ma. Contact Dermatitis. 2020 Mar;82(3):195-200. doi: 10.1111/cod.13437. Epub 2020 Jan 3. Contact Dermatitis. 2020. PMID: 31747053
The feasibility of an allergy management support system (AMSS) for IgE-mediated allergy in primary care.
Flokstra-de Blok BMJ, Brakel TM, Wubs M, Skidmore B, Kocks JWH, Oude Elberink JNG, Schuttelaar MA, van der Velde JL, van der Molen T, Dubois AEJ. Flokstra-de Blok BMJ, et al. Among authors: schuttelaar ma. Clin Transl Allergy. 2018 May 29;8:18. doi: 10.1186/s13601-018-0206-y. eCollection 2018. Clin Transl Allergy. 2018. PMID: 29872524 Free PMC article.
16 results